VC Tavern · May 2026
States the startup raised $6.3M in seed funding and frames the company as building infrastructure to unify and validate complex biomedical, clinical, and human-performance data.
The Infrastructure Powering Human-In-Computer Models
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Mantis Biotech (also branded as Mantis / Mantis Biotechnology Corp.) builds digital-twin and behavioral-forecasting infrastructure for humans, starting in healthcare. It ingests user-consented streams such as wearable physiology, device telemetry, digital activity, and clinical records, then sells scoped, revocable access to predictive outputs rather than raw data. Public sources disagree on headquarters and funding totals: YC/company pages point to New York City, while corporate/profile databases also list San Francisco. No public GitHub or X profile was found in the reviewed sources.
Primary product
Human digital-twin / behavioral forecasting data platform for life sciences and healthcare
Founded
2025
Headquarters
New York City, NY, United States
Team size
1-10 employees
Work style
Flexible
Industry
Biotechnology Research
Open Positions
6 jobs at Mantis Biotechnology
Acquisition, Production and Development Coordinator (TEST)
On-siteGlobal AcquisitionNew York, New York6mo ago
On-site